Amplify Weight Loss Drug & Treatment ETF (THNR)
Amplify Weight Loss Drug & Treatment ETF operates in the Asset Management industry of the Financial Services sector, headquartered in Lisle, IL, US. The stock last traded at $26.50, down 0.40% on the session, giving a market capitalisation of $5.3M. Its beta of 0.38 implies it has historically moved less than the broad market.
The Amplify Weight Loss Drug & Treatment ETF (THNR) offers investors a way to access international firms poised to benefit financially from advancements in weight management pharmaceuticals. Its primary objective is to mirror the investment performance (before any fees or expenses) of the VettaFi Weight Loss Drug & Treatment Index.
Amplify Weight Loss Drug & Treatment ETF is most often compared with the following Financial Services names: